Aceragen | Crediti Commerciali

Trade Debtors Cambiamento Data
Alnylam Pharmaceuticals USD 327.79M 2.34M 2023-12
Amgen USD 7.27B 1.12B 2023-12
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.76M 102K 2023-09
CSL USD 2.24B 796.3M 2023-06
Dynavax Technologies USD 44.53M 2.33M 2023-12
Eli Lilly USD 10.36B 1.19B 2023-09
Gilead Sciences USD 4.66B 130M 2023-12
GlaxoSmithKline GBP 8.87B 1.78B 2023-09
Grifols EUR 908.03M 42.32M 2023-09
Pfizer USD 15B 1.58B 2023-09
Roche Holding CHF 11.36B 560M 2023-06
Sarepta Therapeutics USD 354.26M 87.1M 2023-09
Ultragenyx Pharmaceutical USD 79.26M 8.74M 2023-09



Aceragen Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.